药品注册申请号:074739
申请类型:ANDA (仿制药申请)
申请人:TEVA PHARMS
申请人全名:TEVA PHARMACEUTICALS USA
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG No No AB 1998/11/30 1998/11/30 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/06/24 SUPPL-37(补充) Approval Labeling STANDARD
2020/06/24 SUPPL-36(补充) Approval Labeling STANDARD
2020/06/24 SUPPL-35(补充) Approval Labeling STANDARD
2015/09/24 SUPPL-34(补充) Approval Labeling STANDARD
2015/04/06 SUPPL-33(补充) Approval Labeling STANDARD
2015/04/06 SUPPL-32(补充) Approval Labeling STANDARD
2013/05/31 SUPPL-30(补充) Approval Labeling
2011/03/22 SUPPL-27(补充) Approval Labeling
2010/01/08 SUPPL-26(补充) Approval Labeling
2009/07/22 SUPPL-25(补充) Approval Labeling
2009/01/16 SUPPL-24(补充) Approval Labeling
2008/07/14 SUPPL-23(补充) Approval Labeling
2008/03/12 SUPPL-22(补充) Approval Labeling
2007/08/30 SUPPL-21(补充) Approval Labeling
2007/04/30 SUPPL-20(补充) Approval Labeling
2006/08/07 SUPPL-19(补充) Approval Labeling
2006/04/04 SUPPL-18(补充) Approval Labeling
2005/05/11 SUPPL-15(补充) Approval Labeling
2002/05/24 SUPPL-13(补充) Approval Labeling
2001/04/11 SUPPL-12(补充) Approval Manufacturing (CMC)
2001/04/11 SUPPL-11(补充) Approval Manufacturing (CMC)
2000/12/07 SUPPL-10(补充) Approval Manufacturing (CMC)
2000/12/07 SUPPL-9(补充) Approval Manufacturing (CMC)
2000/12/07 SUPPL-8(补充) Approval Manufacturing (CMC)
2000/02/29 SUPPL-7(补充) Approval Labeling
1999/10/26 SUPPL-5(补充) Approval Manufacturing (CMC)
1999/09/02 SUPPL-3(补充) Approval Labeling
1999/09/02 SUPPL-2(补充) Approval Manufacturing (CMC)
1999/09/02 SUPPL-1(补充) Approval Manufacturing (CMC)
1999/03/23 SUPPL-4(补充) Approval Manufacturing (CMC)
1998/11/30 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:AMIODARONE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:200MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
075135 001 ANDA PACERONE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 1998/04/30 UPSHER SMITH LABS
074739 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 1998/11/30 TEVA PHARMS
075315 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Discontinued No No AB 1998/12/23 UPSHER SMITH LABS
075389 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2001/01/25 DR REDDYS LABS SA
075424 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No Yes AB 2001/03/30 TARO
077069 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2005/04/08 CHARTWELL RX
079029 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2008/09/16 ZYDUS PHARMS USA INC
078578 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2008/11/06 RUBICON
204742 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2016/06/03 AUROBINDO PHARMA LTD
213446 001 ANDA AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE TABLET;ORAL 200MG Prescription No No AB 2020/07/21 UNICHEM
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database